
This new modular analytics platform helps commercial teams refine strategies and improve patient care.
LONDON, Jan. 14, 2025 — (NYSE:CLVT), a leading global provider of advanced intelligence, today introduced DRG Fusion, a cutting-edge platform for commercial analytics in the life sciences sector. Developed by clinical and data science experts and powered by integrated real-world data, Fusion gives biopharma and medtech companies the tools to understand and respond effectively to diverse disease environments and competitive dynamics, simplifying complex raw data management.

Biopharma and medtech companies face growing challenges in extracting actionable insights from scattered data while adapting to competitive pressures and evolving market demands. Fusion tackles these challenges by providing market data and analytics from integrated medical and pharmacy claims and other real-world data sources, enabling life science companies to build a healthier future. Its user-tested workflows and continuous data updates allow teams to rapidly pinpoint weaknesses in product positioning and uncover opportunities to boost patient acquisition and retention.
Fusion directly addresses the needs of biopharma and medtech commercial, sales, and marketing teams by offering modular data analytics products tailored to specific team requirements. Pre-built modules provide users with customizable dashboards to support patient journey analysis, targeted commercial strategies, market access optimization, and patient segmentation.
Abeezer Tapia, Senior Vice President & General Manager, Real-World Data, Life Sciences & Healthcare, Clarivate, commented: “Fusion leverages real-world data to help our clients maximize product value. Its four product workflows address specific goals—whether it’s defining and segmenting target patient groups, pinpointing and mitigating patient journey gaps, deploying sales teams strategically, or crafting value propositions and support programs to optimize access. With data refined at the drug and device level, Fusion offers the focused market insights crucial for biopharma and medtech decision-making.”
Henry Levy, President, Life Sciences & Healthcare, Clarivate, added: “Fusion showcases the power of Clarivate’s life sciences data and its wide-ranging commercial applications. Its scalable data architecture is expertly designed for rapid insight delivery across various patient diseases and sub-populations. We are dedicated to investing in innovative technologies that empower our clients to tackle healthcare’s most urgent challenges. With new AI-driven and self-service features launching in Fusion in 2025, we remain dedicated to delivering user-friendly solutions that create meaningful value and impact for our customers.”
Fusion streamlines data management and querying for life sciences organizations by simplifying complex data analysis with readily available, informative visuals and tables, accelerating commercial decisions.
To learn more about how this modular analytics platform can help organizations optimize their product launch and growth strategies while improving patient outcomes, visit .
About Clarivate Real-World Data
Clarivate offers a unique combination of products and expert consulting to support you at every stage of your real-world data (RWD) journey. Our platform seamlessly integrates medical and pharmacy claims, SDoH, mortality, and registry data to deliver valuable insights across the development lifecycle. With cohort-specific data tailored to your needs, we provide precise answers to key business questions. Our modular analytics platform, created by data scientists, epidemiologists, and former clinicians, provides functional insights to enhance your commercial strategy. We also offer expert assistance in data configuration, advanced ML models, and the integration of disparate datasets to ensure you have the resources and expertise to drive success. Offerings include , , and .
About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit .
Media Contact:
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
Logo –